Abstract
A wide spectrum of endoscopic findings exists in patients with gastroesophageal reflux disease (GERD). This study compared clinical outcomes after laparoscopic antireflux surgery (LARS) in patients who had GERD with and without preoperative endoscopic esophagitis. From 1992 to 2001, a total of 414 patients who underwent LARS with 6 months or more of follow-up were prospectively entered into a database. Among these patients, 84 (20%) had no endoscopic evidence of esophagitis on preoperative endoscopy (group 1), whereas 330 (80%) did have esophagitis (group 2). Perioperative outcomes, GERD symptom relief, and the use of acid-reducing medication were assessed. Preoperative DeMeester scores in groups 1 and 2 were 44 ± 29 and 61 ± 62 (P < 0.05) and mean esophageal peristaltic amplitude was 86 ± 32 mm Hg vs. 60 ± 42 mm Hg, respectively (P < 0.05). Although procedure time was significantly shorter in group 1, other perioperative outcomes were similar. At postoperative follow-up, the use of proton pump inhibitors was reduced in both groups (86% to ≤14%). With the exception of postoperative dysphagia, there was no difference in GERD symptom relief between groups 1 and 2. The presence or absence of preoperative esophagitis has minimal effect on favorable symptomatic outcomes after LARS. Thus LARS is an effective treatment option for patients, irrespective of endoscopic evidence of esophagitis, leading to excellent symptom relief and a marked reduction in the use of proton pump inhibitors.
Similar content being viewed by others
References
Eckhardt VF. Does healing of esophagitis improve esophageal motor function?. Dig Dis Sci 1988;33:161–165.
Winkelstein A. Peptic esophagitis. A new clinical entity. JAMA 1935;104:906–909.
Carlsson R, Holloway RH. Endoscopy-negative reflux disease. Baillieres Clin Gastroenterol 2000;5:827–837.
Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998;10:119–124.
Lauritsen K. Management of endoscopy-negative reflux disease: Progress with short-term treatment. Alimentary Pharmacol Ther 1997;11 (Suppl 2):87–92.
Smout A. Endoscopy-negative acid reflux disease. Alimentary Pharmacol Ther 1997;11 (Suppl 2):81–85.
Bate CM, Green JR, Axon AT, et al. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic esophagitis. Alimentary Pharmacol Ther 1997;11:755–763.
Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: A double blind comparison of omeprazole and cisapride. Alimentary Pharmacol Ther 1997;11:765–773.
Achem SR. Endoscopy-negative gastroesophageal reflux disease: The hypersensitive esophagus. Gastroenterol Clin 1999;28:893–904.
Bowrey DJ, Peters JH. Laparoscopic esophageal surgery. Surg Clin North Am 2000;80:1213–1242.
Watson DI, Foreman D, Devitt PG, Jamieson GG. Preoperative endoscopic grading of esophagitis vs. outcome after laparoscopic Nissen fundoplication. Am J Gastroenterol 1997;92:222–225.
Ollyo JB, Fontolliet Ch, Lang BF. La nouvelle classification de Savary des oesophagites de reflux. Acta Endosc 1992;22:307–320.
Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325–332.
Soper NJ. Laparoscopic management of hiatal hernia and gastroesophageal reflux. Curr Probl Surg 1999;36:765–840.
Clavien PA, SanabriaJR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518–526.
Soper NJ, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999;229:669–677.
Jones RH, Pali A, Hungin S, et al. Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings. Eur J Gen Pract 1995;1:149–154.
Joelsson B, Johnsson F. Heartburn—the acid test. Gut 1989;30:1523–1525.
Lind T, Havelund T, Carlsson R, et al. Heartburn without esophagitis: Efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974–979.
Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997;32:965–973.
Hatlebakk JG, Hyggen A, Madsen PH, et al. Heartburn treatment in primary care: randomized, double blind study for 8 weeks. Br Med J 1999;819:550–553.
Richter JE, Kovacs TOG, Greski-Rose PA, et al. Lansoprazole in the treatment of heartburn in patients without erosive esophagitis. Alimentary Pharmacol Ther 1999;13:795–804.
Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux—the "sensitive esophagus". Gut 1997;40:587–590.
Venables TL, Newland RD, Patel AC, et al. Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997;32:627–632.
Stein HJ, Eypasch EP, Smyrk TC, et al. Circadian esophageal motor function in patients with gastroesophageal reflux disease. Surgery 1990;108:769–778.
Greason KL, Miller DL, Deschamps C, et al. Effects of antireflux procedures on respiratory symptoms. Ann Thorac Surg 2002;73:381–385.
Spivak H, Smith CD, Phichith A, et al. Asthma and gastroe-sophageal reflux: Fundoplication decreases the need for systemic corticosteroids. J Gastrointest Surg 1999;3:477–482.
So JB, Zeitels SM, Rattner DW. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998;124:28–32.
Hunter JG, Trus TL, Branum GD, et al. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996;223:673–685.
Watson DI, Jamieson GG. Antireflux surgery in the laparoscopic era. Br J Surg 1998;85:1173–1184.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Washington University Institute for Minimally Invasive Surgery.
Rights and permissions
About this article
Cite this article
Desai, K.M., Frisella, M.M. & Soper, N.J. Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis. J Gastrointest Surg 7, 44–52 (2003). https://doi.org/10.1016/S1091-255X(02)00135-X
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(02)00135-X